Riccardo Morandin

Verona, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Association between visceral adiposity index and metabolic dysfunction-associated steatotic liver disease in adults with type 1 diabetes mellitus: an exploratory cross-sectional study.

Association between visceral adiposity index and metabolic dysfunction-associated steatotic liver disease in adults with type 1 diabetes mellitus: an exploratory cross-sectional study.

Journal: Journal of endocrinological investigation

Published: June 16, 2026

Dysregulated growth hormone-insulin-like growth factor-1 axis in adults with metabolic dysfunction-associated steatotic liver disease: a meta-analysis.

Dysregulated growth hormone-insulin-like growth factor-1 axis in adults with metabolic dysfunction-associated steatotic liver disease: a meta-analysis.

Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD

Published: May 18, 2026

Bidirectional relationship between metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus.

Bidirectional relationship between metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus.

Journal: EXCLI journal

Published: April 03, 2026

Two-tier screening approach for liver fibrosis stratification in outpatients with type 2 diabetes mellitus: A multicenter cross-sectional study.

Two-tier screening approach for liver fibrosis stratification in outpatients with type 2 diabetes mellitus: A multicenter cross-sectional study.

Journal: Diabetes, obesity & metabolism

Published: September 05, 2025

MASLD in Adults With Type 1 Diabetes and Type 2 Diabetes Undergoing Vibration-Controlled Transient Elastography.

MASLD in Adults With Type 1 Diabetes and Type 2 Diabetes Undergoing Vibration-Controlled Transient Elastography.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: July 30, 2025

Glucagon-Like Peptide-1 Receptor Agonists Improve MASH and Liver Fibrosis: A Meta-Analysis of Randomised Controlled Trials.

Glucagon-Like Peptide-1 Receptor Agonists Improve MASH and Liver Fibrosis: A Meta-Analysis of Randomised Controlled Trials.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: June 26, 2025

A new plasma ceramide 24-based risk score predicts overall mortality and nonfatal myocardial infarction in patients with suspected or known coronary artery disease.

A new plasma ceramide 24-based risk score predicts overall mortality and nonfatal myocardial infarction in patients with suspected or known coronary artery disease.

Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD

Published: February 26, 2025

Sodium-Glucose Cotransporter 2 Inhibitor Use and Risk of Liver-Related Events in Patients With Type 2 Diabetes: A Meta-analysis of Observational Cohort Studies.

Sodium-Glucose Cotransporter 2 Inhibitor Use and Risk of Liver-Related Events in Patients With Type 2 Diabetes: A Meta-analysis of Observational Cohort Studies.

Journal: Diabetes care

Published: February 04, 2025

Ceramide-based risk score CERT-1 improves risk prediction for overall mortality and adverse cardiovascular outcomes in patients with and without cardiovascular disease: A prospective cohort study.

Ceramide-based risk score CERT-1 improves risk prediction for overall mortality and adverse cardiovascular outcomes in patients with and without cardiovascular disease: A prospective cohort study.

Journal: Diabetes, obesity & metabolism

Published: November 13, 2024

MASLD Is Associated With an Increased Long-Term Risk of Atrial Fibrillation: An Updated Systematic Review and Meta-Analysis.

MASLD Is Associated With an Increased Long-Term Risk of Atrial Fibrillation: An Updated Systematic Review and Meta-Analysis.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: November 01, 2024

Basal and post-stress ceramide-based risk score CERT1 predicts all-cause mortality and nonfatal myocardial infarction in patients with suspected or established coronary artery disease undergoing stress myocardial perfusion scintigraphy.

Basal and post-stress ceramide-based risk score CERT1 predicts all-cause mortality and nonfatal myocardial infarction in patients with suspected or established coronary artery disease undergoing stress myocardial perfusion scintigraphy.

Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD

Published: August 01, 2024

Association between MASLD and increased risk of serious bacterial infections requiring hospital admission: A meta-analysis.

Association between MASLD and increased risk of serious bacterial infections requiring hospital admission: A meta-analysis.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: July 13, 2024

Showing 1-12 of 16

Last Updated: 09/26/2026